Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma - Concepedia

Concepedia

Publication | Closed Access

Elevated baseline serum PD-1 or PD-L1 predicts poor outcome of PD-1 inhibition therapy in metastatic melanoma

108

Citations

25

References

2020

Year

Selma Ugurel, Dirk Schadendorf, Kai Horny, Antje Sucker, Sabine Schramm, Jochen Utikal, Claudia Pföhler, Rudolf Herbst, Bastian Schilling, Christian U. Blank,

Annals of Oncology

Cancer ImmunosurveillanceMedicineMelanomaImmunologyMetastatic MelanomaBaseline Serum Pd-1Immune Checkpoint InhibitorPd-1 Inhibition TherapyImmunotherapyOncologyRadiation OncologySkin Cancer

References

	Year	Citations

Page 1

Page 1